Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Ready-to-Use Urine Chemistry Control Convenient and Inexpensive

By LabMedica International staff writers
Posted on 30 May 2012
A liquid urine control is both easy and convenient for laboratory staff to use. More...
It includes fully assayed target values for 18 commonly performed urine chemistry tests including microalbumin and the hormone human chorionic gonadotropin (hCG), and enables consolidation and cost savings.

The control is manufactured from 100% human urine, not only providing a matrix similar to the patient sample but also reducing antibody interference and the possibility of control values shifting after the reagent batch is changed. A 10 mL vial size and an open vial stability of 30 days at 2-8 °C for all parameters ensure that both waste and costs are kept to a minimum.

Eliminating the need for reconstitution, the liquid stable format of the control reduces the amount of human handling and the subsequent risk of pipetting errors. The material can also be economically shipped and stored at 2-8 °C.

Called the Acusera liquid urine control and manufactured by Randox (Crumlin, United Kingdom), it is compatible for use with Acusera 24.7, the company's new web based inter-laboratory data management program. With 24-7, users benefit from the company's extensive range of data management tools and gain access to worldwide peer-group data. Acusera 24.7 updates peer-group data every 24 hours giving laboratories access to the most up to date information available.

Instrument specific target values and ranges are provided for many common clinical chemistry analyzers including Abbott Architect, and a number of Beckman Coulter and Siemens systems.

Related Links:

Randox



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.